Breaking News Instant updates and real-time market news.

2018-04-12 06:36:09 EBS Emergent BioSolutions $53.59 -0.83 (-1.53%) 06:36 04/12/18 04/12 06:36 04/12/18 06:36	Emergent BioSolutions completes BioThrax Mutural Recognition Procedure in Europe Emergent BioSolutions completed the Mutual Recognition Procedure for market authorization of BioThrax in five Concerned Member States within the European Union, including Italy, the Netherlands, Poland, the U.K., and France. Emergent filed the mutual recognition application based on the existing Marketing Authorization of BioThrax in Germany granted by the Paul-Ehrlich-Institut. Following the positive MRP outcome, national licenses are due to be issued shortly by the five CMS countries. Where approved in Europe, BioThrax is indicated for prevention of disease caused by Bacillus anthracis in adults at risk of exposure. BioThrax is also licensed by the FDA for the active immunization for the prevention of disease caused by Bacillus anthracis.
EBS Emergent BioSolutions $53.59 -0.83 (-1.53%) 09/25/17 WELS 09/25/17 NO CHANGE WELS Emergent BioSolutions contract reflects 'strong' visibility, says Wells Fargo Wells Fargo analyst David Maris highlights that Emergent BioSolutions announced earlier today it has been awarded a five year follow-on contract valued at up to $171M by the U.S. Department of Defense to supply Reactive Skin Decontamination Lotion Kit for use by all U.S. military branches. Assuming the $171M is evenly spread over the five year period, the average annual sales would be $34M, Maris tells investors in a research note, pointing out that this is in line with his 2018 forecast. The contract reflects Emergent's "strong, renewed commitment and visibility" for RSDL, the analyst contends. He has an Outperform rating on Emergent BioSolutions. 09/27/17 WELS 09/27/17 NO CHANGE Target $43 WELS Outperform Wells Fargo ups Emergent BioSolutions target to $43 on recent contracts To reflect the recently announced contracts with the Biomedical Advanced Research and Developed Authority and a follow-on contract with the U.S. Department of Defense, Wells Fargo analyst David Maris raised his price target for Emergent BioSolutions to $43 from $41. The analyst views both contracts as in line with the company's continued effort to look for partnerships with the U.S. government and Non-Government Organizations. He maintains an Outperform rating on Emergent. 11/08/17 WELS 11/08/17 NO CHANGE Target $45 WELS Outperform Wells says Emergent deal to sell RSDL products on Amazon 'shows initiative' Wells Fargo analyst David Maris noted that Emergent BioSolutions (EBS) reported higher than expected Q3 revenue and earnings and raised and narrowed its full year sales view, leading him to increase his forecasts and raise his price target on the stock to $45 from $43. He was also "pleasantly surprised" by the announcement that RSDL chemical counter-measure products are now available at Amazon (AMZN), saying he doubts they will be a big seller but "the approach is creative and shows initiative." Maris maintains an Outperform rating on Emergent BioSolutions. 01/24/18 GSCO 01/24/18 INITIATION Target $55 GSCO Neutral Emergent BioSolutions initiated with a Neutral at Goldman Sachs Goldman analyst Dana Flanders initiated Emergent BioSolutions with a Neutral and $55 price target

2018-04-12 06:36:09

EBS

Emergent BioSolutions

$53.59: -0.83 (-1.53%)

06:36

04/12/18

04/12

06:36

04/12/18

06:36

Emergent BioSolutions completes BioThrax Mutural Recognition Procedure in Europe

Emergent BioSolutions completed the Mutual Recognition Procedure for market authorization of BioThrax in five Concerned Member States within the European Union, including Italy, the Netherlands, Poland, the U.K., and France. Emergent filed the mutual recognition application based on the existing Marketing Authorization of BioThrax in Germany granted by the Paul-Ehrlich-Institut. Following the positive MRP outcome, national licenses are due to be issued shortly by the five CMS countries. Where approved in Europe, BioThrax is indicated for prevention of disease caused by Bacillus anthracis in adults at risk of exposure. BioThrax is also licensed by the FDA for the active immunization for the prevention of disease caused by Bacillus anthracis.

EBS Emergent BioSolutions

$53.59: -0.83 (-1.53%)

09/25/17: WELS

09/27/17: WELS

11/08/17: WELS

01/24/18: GSCO

TODAY'S FREE FLY STORIES

WELL Welltower $50.45 -0.57 (-1.12%) , QCP Quality Care Properties $22.72 1.92 (9.23%) 05:32 04/26/18 04/26 05:32 04/26/18 05:32 Hot Stocks	Welltower to acquire Quality Care Properties for $20.75 per share in cash » Welltower (WELL) and… WELL Welltower $50.45 -0.57 (-1.12%) QCP Quality Care Properties $22.72 1.92 (9.23%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 May 03 May 04 May
ALGN Align Technology $245.24 5.72 (2.39%) 05:32 04/26/18 04/26 05:32 04/26/18 05:32 Recommendations	Align Technology analyst commentary » Align Technology should… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	23 May 12 Jun
FB Facebook $159.69 0.03 (0.02%) 05:28 04/26/18 04/26 05:28 04/26/18 05:28 Recommendations	Facebook analyst commentary » Facebook's strong Q1… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
WELL Welltower $50.45 -0.57 (-1.12%) , QCP Quality Care Properties $22.72 1.92 (9.23%) 05:25 04/26/18 04/26 05:25 04/26/18 05:25 Hot Stocks	Breaking Hot Stocks news story on Welltower, Quality Care Properties » Welltower to acquire… WELL Welltower $50.45 -0.57 (-1.12%) QCP Quality Care Properties $22.72 1.92 (9.23%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 May 03 May 04 May
ANTM Anthem $238.81 13.73 (6.10%) 05:22 04/26/18 04/26 05:22 04/26/18 05:22 Upgrade	Anthem rating change » Anthem upgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

FB Facebook $159.69 0.03 (0.02%) 05:20 04/26/18 04/26 05:20 04/26/18 05:20 Recommendations	Facebook analyst commentary » Facebook price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ERN Erin Energy $1.65 -0.825 (-33.33%) 05:18 04/26/18 04/26 05:18 04/26/18 05:18 Hot Stocks	Erin Energy files voluntary petitions under Chapter 11 to pursue reorganization » Erin Energy and certain… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CTXS Citrix $96.54 0.04 (0.04%) 05:16 04/26/18 04/26 05:16 04/26/18 05:16 Recommendations	Citrix analyst commentary » Citrix price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	08 May 08 May 09 May
AMD AMD $9.72 -0.37 (-3.67%) 05:13 04/26/18 04/26 05:13 04/26/18 05:13 Recommendations	AMD analyst commentary » AMD could see… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	02 May
EBAY eBay $40.98 -0.2 (-0.49%) 05:09 04/26/18 04/26 05:09 04/26/18 05:09 Recommendations	eBay analyst commentary » eBay GMV growth… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

TRVG Trivago $4.71 -1.65 (-25.94%) 05:01 04/26/18 04/26 05:01 04/26/18 05:01 Downgrade	Trivago rating change » Trivago downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
HPR HighPoint Resources $6.65 0.14 (2.15%) 04:58 04/26/18 04/26 04:58 04/26/18 04:58 Initiation	HighPoint Resources initiated » HighPoint Resources… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 May
AVY Avery Dennison $106.68 1.195 (1.13%) 04:57 04/26/18 04/26 04:57 04/26/18 04:57 Upgrade	Avery Dennison rating change » Avery Dennison upgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Apr
04:55 04/26/18 04/26 04:55 04/26/18 04:55 General news	Jobless Claims to be reported at 08:30 » Week of 4/21 Jobless… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
04:55 04/26/18 04/26 04:55 04/26/18 04:55 General news	Breaking General news story » Week of 4/25 Fed Balance… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

04:55 04/26/18 04/26 04:55 04/26/18 04:55 General news	Durable Goods Orders to be reported at 08:30 » March Durable Goods… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
04:55 04/26/18 04/26 04:55 04/26/18 04:55 General news	Durable Goods Orders Ex-transportation to be reported at 08:30 » March Durable Goods… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial
WYN Wyndham $117.67 1.83 (1.58%) , LQ La Quinta $19.70 0.08 (0.41%) 04:55 04/26/18 04/26 04:55 04/26/18 04:55 Conference/Events	La Quinta to host special shareholder meeting » Special Shareholder… WYN Wyndham $117.67 1.83 (1.58%) LQ La Quinta $19.70 0.08 (0.41%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Apr 02 May
04:55 04/26/18 04/26 04:55 04/26/18 04:55 General news	Wholesale Inventories [Advance] M/M % hange to be reported at 08:30 » March Wholesale… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
04:55 04/26/18 04/26 04:55 04/26/18 04:55 General news	International Trade in Goods Balance to be reported at 08:30 » March International Trade… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial

04:55 04/26/18 04/26 04:55 04/26/18 04:55 General news	Breaking General news story » Week of 4/16 Money Supply… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial
04:55 04/26/18 04/26 04:55 04/26/18 04:55 General news	Breaking General news story » 6-Month Bill Announcement… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
ABBV AbbVie $91.91 0.57 (0.62%) , ACOR Acorda Therapeutics $22.95 -0.15 (-0.65%) … 04:55 04/26/18 04/26 04:55 04/26/18 04:55 Conference/Events	American Academy of Neurology to hold annual meeting » 2018 Annual Meeting of… ABBV AbbVie $91.91 0.57 (0.62%) ACOR Acorda Therapeutics $22.95 -0.15 (-0.65%) ALXN Alexion $106.07 -0.37 (-0.35%) AKCA Akcea Therapeutics $26.85 0.02 (0.07%) RHHBY Roche TEVA Teva $17.27 -0.28 (-1.60%) UBS UBS $16.78 -0.095 (-0.56%) MDT Medtronic $79.47 0.12 (0.15%) MCK McKesson $151.70 2.76 (1.85%) NVTA Invitae $5.53 -0.15 (-2.64%) IONS Ionis Pharmaceuticals $43.98 -1.35 (-2.98%) IPXL Impax $19.25 -0.65 (-3.27%) DNA Bought by RHHBY DGX Quest Diagnostics $101.17 1.42 (1.42%) ESALY Eisai DEPO Depomed $6.66 -0.17 (-2.49%) CPRX Catalyst Pharmaceuticals $2.64 0.04 (1.54%) BSX Boston Scientific $29.44 1.01 (3.55%) BMRN BioMarin $81.41 0.33 (0.41%) MYL Mylan $38.93 -1.32 (-3.28%) NBIX Neurocrine $78.13 -0.3 (-0.38%) NVS Novartis $76.42 -0.58 (-0.75%) PFE Pfizer $36.69 -0.36 (-0.97%) RARX RA Pharmaceuticals $5.76 -0.2 (-3.36%) SNY Sanofi $40.11 0.335 (0.84%) SYK Stryker $165.44 0.77 (0.47%) SUPN Supernus $47.30 0.55 (1.18%) LLY Eli Lilly $81.17 1.08 (1.35%) BAYRY Bayer AMGN Amgen $174.83 2.92 (1.70%) ALNY Alnylam $94.35 -0.34 (-0.36%) BIIB Biogen $269.47 7.45 (2.84%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Apr 26 Apr 26 Apr 26 Apr 26 Apr 27 Apr 27 Apr 28 Apr 30 Apr 30 Apr 01 May 02 May 02 May 03 May 04 May 07 May 07 May 08 May 09 May 09 May 10 May 17 May 18 May 21 May 21 May 22 May 23 May 23 May 25 May 28 May 30 May 05 Jun 07 Jun 07 Jun 12 Jun 12 Jun 16 Jun 06 Jul 11 Aug 12 Sep 05 Oct 20 Oct 13 Nov 28 Jan
SMMT Summit Therapeutics $13.66 0.13 (0.96%) 04:55 04/26/18 04/26 04:55 04/26/18 04:55 Conference/Events	Summit Therapeutics management to meet with Needham » Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Apr 03 May
RIO Rio Tinto $55.24 -0.44 (-0.79%) 04:55 04/26/18 04/26 04:55 04/26/18 04:55 Conference/Events	Rio Tinto management to meet with RBC Capital » Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	26 Apr 27 Apr

Events

Earnings calls, analyst events, roadshows and more

SUBCY
Today at 07:00

Subsea 7 - SUBCY Conference Calls
SCCO
Today at 07:00

Southern Copper Firm Sponsored Meetings

Edificio Parque Reforma, Mexico City
PEP
Today at 07:45

PepsiCo - PEP Conference Calls
YGE
Today at 08:00

Yingli Green Energy - YGE Conference Calls
NVCR
Today at 08:00

Novocure - NVCR Conference Calls
LSTR
Today at 08:00

Landstar System - LSTR Conference Calls
LEA
Today at 08:00

Lear - LEA Conference Calls
ARR
Today at 08:00

ARMOUR Residential - ARR Conference Calls
WNS
Today at 08:00

WNS Holdings - WNS Conference Calls
MCRN
Today at 08:00

Milacron - MCRN Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	VLRX X VLRX Valeritas Secondary Managers: Oppenheimer & National Securities Priced at: $1.75 13.7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	LASR X LASR nLight IPO Managers: Stifel & Raymond James, Needham, Canaccord, DA Davidson Priced at: $16.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CASA X CASA Casa Systems Secondary Managers: Morgan Stanley & Barclays, Raymond James, Stifel, Macquarie, Northland, William Blair Priced at: $25.00 7.35M Shares SGMO X SGMO Sangamo Secondary Managers: BofA/Merrill, JPMorgan & Cowen Priced at: $16.25 12.31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	QTNT X QTNT Quotient Block Trade Managers: Morgan Stanley $4.30 500K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDAY X CDAY Ceridian HCM Holding IPO Managers: Goldman Sachs, JPMorgan, Credit Suisse & Deutsche Bank, Goldman Sachs, Barclays, Citi, Jefferies, CIBC, Wells Fargo, Baird, Canaccord, Piper Jaffray, William Blair, MUFG $19.00-21.00 21M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CVNA X CVNA Carvana Secondary Managers: Wells Fargo, CITI & Deutsche Bank $29.96 10M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ELOX X ELOX Eloxx Pharmaceuticals Secondary Managers: Citi & Piper Jaffray, Canaccord, SunTrust $10.45 5M Shares TLC X TLC Taiwan Liposome Secondary Managers: Cantor Fitzgerald, CLSA, H.C. Wainwright, Janney Capital, Laidlaw $7.46 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	DOCU X DOCU Docusign IPO Managers: Morgan Stanley & JPMorgan, Citi, BofA/Merrill, Deutsche Bank, JMP Securities, Piper Jaffray, William Blair $26.00-28.00 21.7M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GSHD X GSHD Goosehead Insurance IPO Managers: JPMorgan & BofA/Merrill, KWBI, William Blair $14.00-16.00 8.53M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SMAR X SMAR Smartsheet IPO Managers: Morgan Stanley, JPMorgan & Jefferies, RBC Capital, Canaccord, William Blair, SunTrust $12.00-14.00 11.633M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Emergent BioSolutions completes BioThrax Mutural Recognition Procedure in Europe

TODAY'S FREE FLY STORIES

Get Full Fly Access